Increased risk of cerebrovascular adverse events and death in elderly demented patients treated with atypical antipsychotics: what's a clinician to do?
Nelson
J Craig
JC
University of California, San Francisco, USA.
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002423:Cause of Death; D002561:Cerebrovascular Disorders / Q000139:chemically induced* / Q000453:epidemiology / Q000401:mortality*; D032962:Consent Forms / Q000592:standards; D003704:Dementia / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology; D006801:Humans; D007258:Informed Consent / Q000592:standards; D011618:Psychotic Disorders / Q000188:drug therapy; D012307:Risk Factors; D020458:Third-Party Consent
D014150:Antipsychotic Agents